Conversion of anilines to bis-Boc protected N-methylguanidines

Tetrahedron Letters

Volumn 37, Issue 37, 1996, Pages 6815-6818

  Lammin, Simon G ^a   Pedgrift, Brian L ^a   Ratcliffe, Andrew J ^a  

^a Dagenham Research Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GUANIDINE DERIVATIVE;

ARTICLE; DRUG SYNTHESIS; REACTION ANALYSIS;

EID: 0030576958     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(96)01487-6     Document Type: Article

References (24)

1. 1. "The Organic Chemistry of Drug Synthesis"; Lednicer, D.; Mitscher, L. A., Eds.; Wiley: New York, Vol. I (1977) and Vol II (1980).
2. 2. Yancey, K. B. Clin. Exp. Immunol. 1988, 71, 207.
3. 3. (a) Braun, C. E. J. Am. Chem. Soc. 1933, 55, 1280.
4. (b) King, H.; Tonkin, S. M. J. Chem. Soc. 1946, 1063.
5. (c) Jen, T.; Van Hoeven, H.; Groves, W.; McLean, R. A.; Loev, B. J. Med. Chem. 1975, 18, 90.
6. 4. Hughes, J. L.; Liu, R. C.; Enkoji, T.; Smith, C. M.; Bastian, J. W.; Luna, P. D. J. Med. Chem. 1975, 18, 1077.
7. 5. Poss, M. A.; Iwanowicz, E.; Reid, J. A.; Lin, J.; Gu, Z. Tetrahedron Lett. 1992, 33, 5933.
8. 6. Kim, K. S.; Qian, L. Tetrahedron Lett. 1993, 34, 7677.
9. 7. Maryanoff, C. A.; Stanzione, R. C.; Plampin, J. N.; Mills, J. E. J. Org. Chem. 1986, 51, 1882.
10. 8. Patel, R.; Mahal, A. S.; Burford, D. L. W. PCT Int. Appl. 1994, WO 9426701.
11. 9. (a) Chauhan, V. S.; Young, G. T.; Bowery, N. G. Bioorg. Chem. 1979, 8, 333.
12. (b) Karadavidoff, I.; Moreau, M. U.S. Patent 3 925 552, 1975.
13. 10. Bernatowicz, M. S.; Wu, Y.; Matsueda, G. R. J. Org. Chem. 1992, 57, 2497.
14. 11. Bergeron, R. J.; McManis, J. S. J. Org. Chem. 1987, 52, 1700.
15. 12. Iwanowicz, E. J.; Poss, M. A.; Lin, J. Synth. Commun. 1993, 23, 1443.
16. 1H nmr and C, H, N analysis or mass spectra.
17. 1H nmr spectrum was evident with 5 over a 6 month period.
18. 8S: C, 39.35; H, 1.65; N, 15.30; S, 8.76. Found: C, 39.48; H, 1.58; N, 15.25; S, 8.53.
19. 16. Beilstein, F.; Kurbatow, A. Justus Liebigs Ann. Chem. 1879, 197, 77.
20. 17. (a) Pilgram, K. Tetrahedron, 1967, 23, 3007.
21. (b) Evans, T. L.; Kinnard, R. D. J. Org. Chem. 1983, 48, 2496.
22. 18. The biological activity of 12 as a C-5a antagonist will be reported in due course.
23. 19. (a) Bernatowicz, M. S.; Wu, Y.; Matsueda, G. R. Tetrahedron Lett. 1993, 34, 3389.
24. (b) Drake, B.; Patek, M.; Lebl, M. Synthesis 1994, 579.